Loading...
Organon & Co.
OGN•NYSE
HealthcareDrug Manufacturers - General
$9.55
$0.36(3.92%)
Organon & Co. (OGN) Financial Performance & Statements
Review Organon & Co.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
2.24%
↑ 2.24%
Operating Income Growth
11.98%
↑ 11.98%
Net Income Growth
-15.54%
↓ 15.54%
Operating Cash Flow Growth
17.52%
↑ 17.52%
Operating Margin
22.20%
↑ 22.20%
Gross Margin
57.18%
↑ 57.18%
Net Profit Margin
11.92%
↑ 11.92%
ROE
181.71%
↑ 181.71%
ROIC
13.25%
↑ 13.25%
Organon & Co. (OGN) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Organon & Co. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.59B | $1.58B | $1.61B | $1.62B |
| Cost of Revenue | $696.00M | $659.00M | $668.00M | $665.00M |
| Gross Profit | $896.00M | $923.00M | $939.00M | $957.00M |
| Gross Profit Ratio | $0.56 | $0.58 | $0.58 | $0.59 |
| R&D Expenses | $130.00M | $111.00M | $116.00M | $112.00M |
| SG&A Expenses | $470.00M | $422.00M | $437.00M | $431.00M |
| Operating Expenses | $600.00M | $533.00M | $553.00M | $543.00M |
| Total Costs & Expenses | $1.30B | $1.19B | $1.22B | $1.21B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $132.00M | $126.00M | $131.00M | $131.00M |
| Depreciation & Amortization | $77.00M | $69.00M | $66.00M | $65.00M |
| EBITDA | $341.00M | $402.00M | $432.00M | $479.00M |
| EBITDA Ratio | $0.21 | $0.25 | $0.27 | $0.30 |
| Operating Income | $296.00M | $390.00M | $386.00M | $414.00M |
| Operating Income Ratio | $0.19 | $0.25 | $0.24 | $0.26 |
| Other Income/Expenses (Net) | -$167.00M | -$183.00M | -$151.00M | -$178.00M |
| Income Before Tax | $129.00M | $207.00M | $235.00M | $236.00M |
| Income Before Tax Ratio | $0.08 | $0.13 | $0.15 | $0.15 |
| Income Tax Expense | $20.00M | -$152.00M | $40.00M | $35.00M |
| Net Income | $109.00M | $359.00M | $195.00M | $201.00M |
| Net Income Ratio | $0.07 | $0.23 | $0.12 | $0.12 |
| EPS | $0.42 | $1.39 | $0.76 | $0.79 |
| Diluted EPS | $0.42 | $1.38 | $0.75 | $0.78 |
| Weighted Avg Shares Outstanding | $257.69M | $257.50M | $257.29M | $255.69M |
| Weighted Avg Shares Outstanding (Diluted) | $259.88M | $259.76M | $258.60M | $258.36M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan